Our major mission is to become a truly international society, which can facilitate and accelerate commercialization of innovative biotherapeutics. To achieve our primary objective, this year’s Asia Pacific Consortium of Gene and Cell Therapy (APCGCT) brings together leading experts of gene and cell therapy from industrial, clinician, academic, and drug regulatory backgrounds. The main focus of the Society is to foster camaraderie and scientific collaboration among several entities that are integral to bringing innovative therapeutic solutions to patients worldwide.
Currently 15 types of gene therapeutics that have been commercialized throughout the world. Further, recent clinical breakthrough and remarkable therapeutic benefits of CAR-T therapies forecast that gene and cell therapeutics will continue to be of great importance for cancer therapy of the present and the future. We believe that 2019 will be a year to build on this remarkable upward trajectory and take another step forward to improve patient outcomes.
We cordially invite you to participate in the Annual Meeting of the Asia Pacific Consortium of Gene and Cell Therapy (APCGCT) in Seoul over November 7-8th, 2019 to further accelerate and improve biopharmaceutical development process.
In accordance with rapid transformation in the biotherapeutic market, annual conference of APCGCT aims to provide most up-to-date information and development within the field of gene and cell therapy that accurately represents the evolving market this year. APCGCT 2019 is the first symposium to be held in Korea, which brings together about 25 world-renown experts and scholars from diverse backgrounds (academia, drug regulatory body, clinic, and pharmaceutical industry). Experts will provide innovative presentation and vibrant discussion on current trend of research, development in translation research, recent clinical trial results, and commercialization process of gene and cell therapeutics.
Ultimately, we firmly believe that APCGCT2019 can serve as a rendezvous point for leading experts from diverse backgrounds to exchange innovative ideas and forge strong and beneficial partnerships to exponentially expedite commercialization of promising gene and cell therapeutics.
With all our colleagues and friends from the APCGCT board, we sincerely wish you will partake in an exciting and productive meeting.